| Literature DB >> 27080914 |
Henryk Barthel1, Philipp T Meyer, Alexander Drzezga, Peter Bartenstein, Henning Boecker, Peter Brust, Ralph Buchert, Heinz H Coenen, Christian la Fougère, Gerhard Gründer, Frank Grünwald, Bernd J Krause, Torsten Kuwert, Matthias Schreckenberger, Klaus Tatsch, Karl-Josef Langen, Osama Sabri.
Abstract
Recently, a number of positron emission tomography (PET) radiotracers have been approved for clinical use. These tracers target cerebral beta-amyloid (Aβ) plaques, a hallmark of Alzheimer's disease. Increasing use of this method implies the need for respective standards. This German Society of Nuclear Medicine guideline describes adequate procedures for Aβ plaque PET imaging. It not only discusses the tracers used for that purpose, but also lists measures for correct patient preparation, image data generation, processing, analysis and interpretation. With that, this "S1" category (according to the German Association of the Scientific Medical Societies standard) guideline aims at contributing to quality assurance of nuclear imaging in Germany.Entities:
Keywords: Beta-amyloid; PET; guideline; plaques; positron emission tomography
Mesh:
Substances:
Year: 2016 PMID: 27080914 DOI: 10.3413/Nukmed-0816-16-04
Source DB: PubMed Journal: Nuklearmedizin ISSN: 0029-5566 Impact factor: 1.379